Last reviewed · How we verify

NCT05072678: MASTOS

Clinical and Radiological Evaluation of Two Mastoid Filling Products

Status unknown Last updated 11 October 2021
What this trial tests

trial in Prospective Study in 20 participants. Status unknown.

Timeline
25 April 2021
Primary endpoint
25 April 2022
25 April 2023

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date25 April 2021
Primary completion25 April 2022
Estimated completion25 April 2023
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Brest

Who can join

Adults 18 to 80, any sex, with Prospective Study. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

to compare, the osseous density in the mastoid of two products used to obliterate the mastoid during surgery for cholesteatoma

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prospective Study

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05072678.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing